Skip to main content
Journal ArticleOPEN ACCESS

The evolution of mendelian randomization for investigating drug effects

  • Gill D
  • Burgess S
PLOS Medicine (2022) 19(2) e1003898
DOI: 10.1371/journal.pmed.1003898
N/ACitations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

Dipender Gill and Stephen Burgess discuss the accompanying study by James Yarmolinsky and colleagues investigating the associations between genetically-proxied inhibition of antihypertensive drug targets and risk of common cancer subtypes using Mendelian randomization.

Cite

CITATION STYLE

APA

Gill, D., & Burgess, S. (2022). The evolution of mendelian randomization for investigating drug effects. PLOS Medicine, 19(2), e1003898. https://doi.org/10.1371/journal.pmed.1003898

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free